Amicogen financials at a glance

+ Portfolio

The revenue of Amicogen is reported as 32.6759 billion Won in the fiscal year 2023. The earnings were 64.07 Won per share in 2023, which was 0 higher than 2015. And about 11.02947 billion Won are reported as free cash flow in the financials of Amicogen 2023. No dividends were paid to the shareholders of the Amicogen stock KOSDAQ:A092040 in the financial year 2023.

₩32.68B

Revenue

₩64.07

Earnings Per Share

34.17%

Gross Margin %

₩0.00M

Free Cash Flow

Revenue

32,675.90

Earnings Per Share

64.07

Gross Margin %

34.17

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2015	2014	2013
Rev.	Revenue	N/A	₩32.68B	₩32.68B	₩27.33B	₩0.00M
GM %	Gross Margin %	33.47%	34.17%	35.68%	50.12%	51.31%
OM	Operating Margin	0.69%	0.43%	7.20%	34.51%	37.93%
EPS	Earnings Per Share	₩-,744.63	₩64.07	₩64.07	₩220.75	₩258.50
Div.	Dividends	N/A	₩25.00	₩25.00	₩0.00	₩0.00
PR %	Payout Ratio %	0	39.02%	39.02%	0	0
Sha.	Shares	N/AM	54.51M	36.46M	34.42M	16.86M
OCF	Operating Cash Flow	N/A	₩12.34B	₩12.34B	₩4.43B	₩0.00M
FCF	Free Cash Flow	N/A	₩11.03B	₩6.54B	₩-,176.76M	₩0.00M
FCFS	Free Cash Flow Per Share	₩-1,180.40	₩-1,352.17	₩286.73	₩-58.38	₩221.65

Amicogen financials at a glance

Financials

Discover